Publications

March 2013
Teaching Note

Nestlé: Agricultural Material Sourcing Within the Concept of Creating Shared Value (CSV) (TN)

By: Ray A. Goldberg and Matthew Preble

In December 2012, Hans Jöhr, Nestlé's head of corporate agriculture, was preparing to meet with the company's board of directors to discuss its vision for the future related to sustainable agriculture. Nestlé's continued success depended on its ability to access the... View Details

Keywords: Sustainability; Sustainability Management; Agribusiness; Environmental Sustainability; Food; Nutrition; Agriculture and Agribusiness Industry

November 2009 (Revised January 2011)
Case

International AIDS Vaccine Initiative

By: Allen S. Grossman and Cathy Ross

Dedicated to accelerating the development of a safe, effective, accessible, preventive HIV vaccine, the International AIDS Vaccine Initiative (IAVI) pioneered ways of addressing the inadequate incentive structures that prevented progress toward vaccines for AIDS and... View Details

Keywords: Developing Countries and Economies; Globalized Firms and Management; Health Care and Treatment; Health Disorders; Business and Government Relations; Partners and Partnerships; Research and Development; Social Enterprise; Health Industry

Find at Harvard

2016
Case

Advanced Leadership Pathways: Doug Rauch and the Daily Table

By: Rosabeth M. Kanter, Peter Zimmerman and Penelope Rossano

Former Trader Joe's President Doug Rauch developed an innovative idea to address the challenge of food insecurity, food waste, and nutrition. His concept was a new retail grocery model, offering nutritious affordable food to a food insecure population in the inner city... View Details

Keywords: Food Insecurity; Grocery; Social Entrepreneurship; Food; Health; Nonprofit Organizations; Boston

30 Aug 2011
First Look

First Look: August 30

311-118 Worldwide, and in the U.S. marketplace in particular, the French cachet of L'Oréal was one of its most powerful marketing tools. However, with the opening up of emerging markets, L'Oréal had to cater to a diverse customer base: an aging View Details

Keywords: Sean Silverthorne

16 Aug 2024
In Practice

Election 2024: What's at Stake for Business and the Workplace?

should be viewed as a way to unlock new opportunities for receiving countries and their populations for decades to come. Marco Tabellini is an assistant professor in the Business, Government, and International Economy Unit. Rosabeth Moss... View Details

Keywords: by Rachel Layne

03 Apr 2009
Working Paper Summaries

Applying the Care Delivery Value Chain: HIV/AIDS Care in Resource Poor Settings

Keywords: by Joseph Rhatigan, Sachin Jain, Joia S. Mukherjee & Michael E. Porter; Health

03 Mar 2008
First Look

First Look: March 4, 2008

the most important components of saving plans, do they even plan for retirement? This paper shows that financial illiteracy is widespread among the U.S. population and particularly acute among specific demographic groups, such as those... View Details

Keywords: Martha Lagace

October 2009 (Revised August 2014)
Case

Tengion: Bringing Regenerative Medicine to Life

By: Elie Ofek and Polly Ross Ribatt

Tengion is a young biotech company that is at the frontier of regenerative medicine—a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late... View Details

Keywords: Decision Choices and Conditions; Financial Crisis; Entrepreneurship; Health Care and Treatment; Technological Innovation; Product Launch; Product Development; Research and Development; Biotechnology Industry; United States

October 2010 (Revised November 2010)
Background Note

Plavix: Drugs in the Age of Personalized Medicine

By: Richard G. Hamermesh, Mara G. Aspinall and Rachel Gordon

PIavix, one of the world's best selling drugs in 2010, appears to have a limited future. Its patent was due to expire soon, and recently new data had been discovered that indicated that a small subset of the population would be at risk for stroke, heart attack, or even... View Details

Keywords: Health Care and Treatment; Product Positioning; Business and Government Relations; Genetics; Competitive Strategy; Pharmaceutical Industry

30 May 2024
Research & Ideas

Racial Bias Might Be Infecting Patient Portals. Can AI Help?

convenience and speed. The report’s conclusion invites further study. Explanations for the disparities that the authors document range from differences in the types of questions or requests made by patients in the messages, the syntax of the message and its level of... View Details

Keywords: by Ben Rand; Health

23 Dec 2014
First Look

First Look: December 23

to the global population was a challenge. Health care costs accounted for 10% of world GDP by 2013. In the U.S., health care costs were expected to top $3.1 trillion in 2014.... View Details

Keywords: Carmen Nobel

30 Mar 2010
First Look

First Look: March 30

outcomes salient (Burns & Corpus, 2004), the bias did not emerge when the presentation did not draw attention to recent outcomes. Fixing Health Care on the Front Lines Author:Richard M.J. Bohmer Publication:Harvard Business Review 88,... View Details

Keywords: Sean Silverthorne

2018
Working Paper

Zig-Zagging Your Way to Transformative Impact

By: V. Kasturi Rangan and Tricia Gregg

Achieving transformative impact has been much discussed by social entrepreneurs, funders, and consultants. These discussions have focused on issues of increasing impact and scale, but often with no clear distinction between the two terms. In order to provide clarity,... View Details

Keywords: Social Entrepreneurship; Performance Efficiency; Growth and Development; Outcome or Result; Strategy

2010
Chapter

From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance

By: Arthur A. Daemmrich

Adverse drug reactions pose distinct but potentially catastrophic risks to patients, physicians, pharmaceutical firms, and regulators. Between the early 1960s and the present, national systems were built to collect, standardize, and respond to individual reports of... View Details

Keywords: Governing Rules, Regulations, and Reforms; Health Testing and Trials; Business and Government Relations; Risk and Uncertainty; Safety; Pharmaceutical Industry; United States

Find at Harvard

January 2024 (Revised April 2024)
Case

Target Malaria: Editing Mosquitoes through Gene Drives

By: Shikhar Ghosh and Shweta Bagai

Target Malaria, a non-profit research consortium, is exploring the application of CRISPR-Cas9 gene editing technology to combat malaria in Sub-Saharan Africa. Its approach uses gene drives, a revolutionary tool, to suppress the population of malaria-carrying... View Details

Keywords: Health Disorders; Technological Innovation; Nonprofit Organizations; Business Strategy; Genetics; Ethics; Governing Rules, Regulations, and Reforms; United States; United Kingdom; Burkina Faso; Africa

26 Mar 2019
First Look

New Research and Ideas, March 26, 2019

record health worker attendance and patient adherence to protocol, and they automatically prompt follow-up treatment. We combine data from surveys, independent field visits, and government registers to identify impacts on TB-control... View Details

Keywords: Dina Gerdeman

03 Oct 2023
Research Event

Build the Life You Want: Arthur Brooks and Oprah Winfrey Share Happiness Tips

when they have very intense negative emotions there's something wrong with them. No, on the contrary, half of the population has unusually intense negative emotions. So one of the things that we do is we use a very famous psychological... View Details

Keywords: by HBS Staff

11 Feb 2014
First Look

First Look: February 11

Publications August 2013 American Journal of Managed Care The Impact of Electronic Health Record Use on Physician Productivity By: Adler-Milstein, Julia, and Robert S. Huckman Abstract—Objectives: To examine the impact of the degree of... View Details

Keywords: Sean Silverthorne

2018
Chapter

The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century

By: Nicholas Bagley, Benjamin Berger, Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern

On the 35th anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades. The most prominent example is the fact that the profit-maximizing price of new... View Details

Keywords: Health Care and Treatment; Laws and Statutes; Research and Development; Investment; Markets; Monopoly